Skip to main content
. 2009 Apr 15;2009(2):CD001290. doi: 10.1002/14651858.CD001290.pub2

NCICAS.

Methods STUDY DESIGN: Parallel group 
 LOCATION, NUMBER OF CENTRES: 8 sites located in inner city American conurbations 
 DURATION OF STUDY: 2 years
Outcome assessors were blinded
Participants N SCREENED: 2847 
 N RANDOMISED: 1033 (treatment: 515; control: 518) 
 N COMPLETED: Not clear 
 M = 661 
 F = 372 
 MEAN AGE: 7.7 
 BASELINE DETAILS: African American: 75%; caretaker smokes: 42%; hospitalisation in previous month: 4.5% 
 INCLUSION CRITERIA: English/Spanish‐speaking; 5 to 11 years; physician‐diagnosed asthma; resident in inner city; use 2 or more medications for asthma, asthma hospitalisation and one unscheduled visit for asthma in 6 months prior to study. Alternatively child had to have symptoms for more than 2 days/sleep disruption for more than 2 nights during 2 weeks prior to study entry 
 EXCLUSION CRITERIA: Not stated
Interventions EDUCATION GROUP: Intervention delivered to caretaker of child by counsellor who encouraged better communication between family and physician. Primary care physician sent asthma care plan, a spacer, a peak flow meter, and asthma guidelines. Caretakers invited to attend 2 group sessions and individual meeting with their counsellor during 2 months after baseline. Group sessions covered triggers, environmental controls, asthma physiology, strategies for problem solving, and communicating with their child's physician. Children participated in group sessions during following 2‐month period. Additionally, bedding provided to families in intervention group & encouraged to minimise exposure to environmental triggers (tobacco and pet exposure).
Counsellor maintained contact with families via telephone every 2 months, tailoring contact based on risk assessment (allergen and trigger exposure, access to care, adherence)
Setting: Home
CONTROL GROUP: Usual care
Arrangements made to assign a primary care physician for participants in both the intervention and control groups without one
TREATMENT PERIOD: 4 months 
 FOLLOW‐UP PERIOD: 2 years
Outcomes Symptoms; ED visits; hospitalisation
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Adequate sequence generation? Unclear risk Block randomisation within site
Allocation concealment? Unclear risk Information not available
Incomplete outcome data addressed? 
 All outcomes Unclear risk Intention‐to‐treat analysis; no explicit description of how data were analysed for hospital contact outcomes